CRISPR Therapeutics AG (CRSP)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

$55.38

Buy

$56.00

arrow-up$1.02 (+1.86%)

Prices updated at 19 Dec 2025, 21:50 EST

Prices minimum 15 mins delay

Prices in USD

CRISPR Therapeutics AG is a gene editing company. It is engaged in the development of CRISPR/Cas9-based therapeutics.

NASDAQ

1.31%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

	$56.68 - $55.00
	$78.48 - $30.04
	-
	5,226.26m
	-
	-
	3,281,846
	2.73
	2,493,468.16
	3.24
	85.91m
	CH0334081137
	-5.54
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.